je.st
news
Home
›
Promus PREMIER(TM) Everolimus-Eluting Platinum Chromium Stent System Receives CE Mark Approval
Promus PREMIER(TM) Everolimus-Eluting Platinum Chromium Stent System Receives CE Mark Approval
2013-02-12 06:00:00| Industrial Newsroom - All News for Today
The Next Advance in Durable Polymer Stent Technology from Boston Scientific is Now Available in Europe and Other Select Geographies NATICK, Mass. - Boston Scientific Corporation (NYSE: BSX) has received CE Mark approval for the Promus PREMIER(TM) Everolimus-Eluting Platinum Chromium Coronary Stent System, the company's next-generation durable polymer drug-eluting stent (DES) technology, and is starting its European market launch. The Promus PREMIER Stent System is designed to provide ...This story is related to the following:Stents
Tags: system
mark
approval
receives
Category:Industrial Goods and Services
Latest from this category |
All news |
||||||||||||||||||||||
|
|
||||||||||||||||||||||